Since the first time she treated a child with neuroblastoma, Giselle Saulnier Sholler wanted to do the impossible for her patients. Neuroblastoma is the most common extracranial solid tumor in children with roughly 700 new diagnoses every year. The survival rate is 30% and for patients who relapse following conventional standard of care treatments, the survival rate is less than 10%.
